Cancer Currents: An NCI Cancer Research Blog
A blog featuring news and research updates from the National Cancer Institute.
-
A new study shows that specific DNA changes in a tumor may help determine which patients are most likely to respond to treatment with PD-1 inhibitors
-
The FDA granted accelerated approval of panobinostat for the treatment of multiple myeloma that has progressed after at least two prior standard therapies.
-
Injecting customized DNA “rings” into tumor-bearing mice caused the tumor cells to release a biomarker that can be detected with a simple blood test.
-
According to a new study, smoking may be responsible for far more deaths each year than previously thought.
-
In a large clinical trial, giving a hormone-suppressing drug helped some younger women with breast cancer get pregnant after completing cancer treatment.
-
At the recent annual Conference on Retroviruses and Opportunistic Infections, several NCI researchers and NCI-funded investigators presented important new findings on HIV-related cancers.
-
The FDA has approved lenvatinib (Lenvima) to treat some patients with the most common type of thyroid cancer.
-
Researchers have identified genetic variations in children with brain cancer that increased their risk of rapid hearing loss after treatment.
-
NCI is constantly publishing new information on its websites, so periodically we provide updates on new content of interest to the cancer community.
-
NCI's Dr. Mark Gilbert discusses new developments in neuro-oncology and the priorities of the Neuro-Oncology Branch.